About Ikris Pharma Network Private Limited
Data last updated:
Ikris Pharma Network Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 13 August 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74120UP2014PTC065470. Its GSTIN is 09AADCI6001P1ZD (Uttar Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Bharat Sikri and Parveen Sikri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No. – 5. 9th Floor Plot No – 40 Tower – A Sector – 62, Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.61 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹1.2 Cr (net margin 5.5%) and EBITDA of ₹2 Cr (EBITDA margin 9.2%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 57% over five years.
The company has about 10 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Ikris Pharma Network.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ikrispharmanetwork.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressUnit No. – 5. 9th Floor Plot No – 40 Tower – A Sector – 62, Noida, Uttar Pradesh, India – 201301
- IndustryBusiness Outsourcing, Business & IT Consulting
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Ikris Pharma Network Private Limited
Ikris Pharma Network operates one associated brand: Ikris Pharma Network. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides clinical trial sourcing services. | ikrispharmanetwork.com |
Competitors & Alternatives of Ikris Pharma Network Private Limited
Brands and companies operating in the same space as Ikris Pharma Network Private Limited include Lightship, SFJ Pharmaceuticals, N-Power Medicine and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Lightship | Direct-to-patient clinical trial solutions are provided by Lightship. | El Segundo, United States | 1995 |
 SFJ Pharmaceuticals | Specialty pharmaceutical company based on partnering model | Pleasanton, United States | 2008 |
 N-Power Medicine | Clinical trial services are provided to support medical research initiatives. | Redwood City, United States | 2021 |
 Clario | CRO focused on providing clinical trial supply services for biopharma sector | Philadelphia, United States | 1972 |
 CRYOPDP | Provider of cold chain clinical trial logistics services | 1992 | |
 Adams Clinical | Late-phase psychiatric and neurologic clinical trials are specialized in. | Watertown, United States | 2011 |
 Cognivia | Provider of data modeling and patient insights for clinical trial optimization | Mont Saint Guibert, Belgium | 2013 |
 Yunu | Clinical trial imaging workflow and data management technology is provided. | Cary, United States | 2022 |
 Accel Research Sites | Clinical trial services are provided for medical research and development. | Deland, United States | 1998 |
Business Activity of Ikris Pharma Network Private Limited
The main business activities of Ikris Pharma Network are hospital and medical care and trade. In detail, this covers other hospital and medical care activities and retail trading. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Ikris Pharma Network Private Limited
Ikris Pharma Network Private Limited is audited by NITIN MITTAL & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NITIN MITTAL & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ikris Pharma Network Private Limited
Ikris Pharma Network has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bharat Sikri Also directs: Dotcom Pharma Private Limited | Director | 13 Aug 2014 | 12 Years 1 Months | Current |
| Parveen Sikri Also directs: Sattva Shilp LLP, Dotcom Pharma Private Limited | Director | 13 Aug 2014 | 12 Years 1 Months | Current |
Financials of Ikris Pharma Network Private Limited FY 2025 filings available
Ikris Pharma Network Private Limited reported revenue of ₹21.61 Cr (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Ikris Pharma Network Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 57% over five years, including 16% growth in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ikris Pharma Network Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.2 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ikris Pharma Network Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ikris Pharma Network are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Ikris Pharma Network Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ikris Pharma Network Private Limited
Ikris Pharma Network Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ikris Pharma Network Private Limited
Ikris Pharma Network Private Limited has a workforce of 10 employees as of Apr 01, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Ikris Pharma Network Private Limited
Ikris Pharma Network has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCI6001P1ZD | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Ikris Pharma Network Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ikris Pharma Network Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ikris Pharma Network Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ikris Pharma Network Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Ikris Pharma Network Private Limited
Frequently Asked Questions about Ikris Pharma Network Private Limited
Ikris Pharma Network is an active private limited company based in Noida, Uttar Pradesh, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 13 August 2014 (12+ years old) and is registered under CIN U74120UP2014PTC065470.
Ikris Pharma Network reported revenue of ₹21.61 Cr for FY 2025 (up 16% YoY).
Ikris Pharma Network has 2 current directors:
- Bharat Sikri - Director
- Parveen Sikri - Director
Ikris Pharma Network reported a net profit of ₹1.2 Cr (net margin 5.5%) and EBITDA of ₹2 Cr (EBITDA margin 9.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ikris Pharma Network is 36% over three years and 57% over five years. In the latest year (FY 2025) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ikris Pharma Network is 09AADCI6001P1ZD, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Ikris Pharma Network is U74120UP2014PTC065470. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ikris Pharma Network was incorporated on 13 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Kanpur.
Ikris Pharma Network can be reached through the website ikrispharmanetwork.com. Its registered office is in Noida, Uttar Pradesh, India.